Stock Market Live June 10, 2026: S&P 500 (SPY) Sinks on Fear of War

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | Oct 22, 2015 at 4:31 PM EDT

How FDA Warning Could Spell Disaster for AbbVie and Opportunity for Gilead

ThinkstockThe U.S. Food and Drug Administration (FDA) issued a warning that hepatitis C treatments, Viekira Pak and Technivie, can cause…

Jon C. Ogg | Oct 22, 2015 at 1:05 PM EDT

Merrimack Pharma Wins FDA Approval of Metastatic Pancreatic Cancer Drug

Merrimack Pharmaceuticals saw its shares halted for "news pending" due to an approval from the FDA.

Jon C. Ogg | Oct 22, 2015 at 12:25 PM EDT

Community Health Systems Rocked on Lower Guidance, Hospital Woes Continue

ThinkstockCommunity Health Systems Inc. (NYSE: CYH) is showing that the weakness in hospital and medical care facilities may not be…

Chris Lange | Oct 22, 2015 at 11:55 AM EDT

Envision Falls Short on Earnings and Guidance

Envision Healthcare was leading the bears in Thursday’s trading session after reporting its third-quarter earnings

Chris Lange | Oct 22, 2015 at 11:50 AM EDT

Viventia Files for IPO

Viventia Bio has filedwith the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).

Chris Lange | Oct 22, 2015 at 10:45 AM EDT

Eli Lilly Rises on Bottom Line Beat

Eli Lilly reported mixed third-quarter financial results on Thursday before the markets opened.

Trey Thoelcke | Oct 22, 2015 at 8:25 AM EDT

The Strongest Performing Biotech in 2015 Is a Surprise

ThinkstockBiotech is still in a rut for 2015, with stocks year to date being essentially unchanged. Since January 1, the…

Douglas A. McIntyre | Oct 22, 2015 at 6:53 AM EDT

Marijuana Use Doubles in 10 Years

If the federal government eventually makes pot use legal across the country, the decision will not come without substantial medical…

Chris Lange | Oct 21, 2015 at 4:59 PM EDT

Neogenomics Gears Up to Acquire GE’s Clarient

ThinkstockNeogenomics Inc. (NASDAQ: NEO) is leading the bulls in Wednesday’s trading session on news of an acquisition. The company announced…

Chris Lange | Oct 21, 2015 at 2:30 PM EDT

What to Expect From Eli Lilly Earnings

Eli Lilly is scheduled to report its third-quarter earnings before the markets open on Thursday.

Chris Lange | Oct 21, 2015 at 9:40 AM EDT

Biogen Beats on Both Top and Bottom Lines

Biogen reported better-than-expected third-quarter financial results Wednesday before the market opened.

Chris Lange | Oct 20, 2015 at 12:20 PM EDT

Corbus Wins With FDA Fast Track Designation

Corbus Pharmaceuticals announced that the FDA has designated as a Fast Track development program and granted Orphan Drug Designation to…

Chris Lange | Oct 20, 2015 at 12:10 PM EDT

Merus Files for IPO

Merus has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).

Lee Jackson | Oct 20, 2015 at 10:05 AM EDT

Q3 Worst for Biotech in 7 Years: Which Large Cap Leaders to Buy Now

Cowen says the way to play biotech is with large cap sector leaders that can beat earnings estimates. It also…

Chris Lange | Oct 19, 2015 at 1:55 PM EDT

Myokardia Sets Terms for IPO

MyoKardia expects to price more than 4 million shares in the range of $15 to $17 in an IPO valued…

1 … 238 239 240 241 242 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

How FDA Warning Could Spell Disaster for AbbVie and Opportunity for Gilead

Merrimack Pharma Wins FDA Approval of Metastatic Pancreatic Cancer Drug

Community Health Systems Rocked on Lower Guidance, Hospital Woes Continue

Envision Falls Short on Earnings and Guidance

Viventia Files for IPO

Eli Lilly Rises on Bottom Line Beat

The Strongest Performing Biotech in 2015 Is a Surprise

Marijuana Use Doubles in 10 Years

Neogenomics Gears Up to Acquire GE’s Clarient

What to Expect From Eli Lilly Earnings

Biogen Beats on Both Top and Bottom Lines

Corbus Wins With FDA Fast Track Designation

Merus Files for IPO

Q3 Worst for Biotech in 7 Years: Which Large Cap Leaders to Buy Now

Myokardia Sets Terms for IPO

Stock Market Live June 10, 2026: S&P 500 (SPY) Sinks on Fear of War

Live Nasdaq Composite: Market Rout Deepens as Inflation Hits Three-Year High and Oil Climbs

SCHD vs. VYM: Which Dividend ETF Builds a Better Income Stream?

The Roth Conversion Window Before Social Security: A Retiree’s Tax Strategy Worth $66,000

Trump Has Declared an Iran Deal Imminent 37 Times Already. When Will The Conflict Truly End?

The Roth Conversion Window Before Social Security: A Retiree's Tax Strategy Worth $66,000

What $6,500 a Month Really Looks Like in Retirement With a $1.7 Million Portfolio

SCHD vs. VYM: Which Dividend ETF Builds a Better Income Stream?

The Roth Conversion Window Before Social Security: A Retiree’s Tax Strategy Worth $66,000

Health and Healthcare Articles

All Health and Healthcare Articles

How FDA Warning Could Spell Disaster for AbbVie and Opportunity for Gilead

Merrimack Pharma Wins FDA Approval of Metastatic Pancreatic Cancer Drug

Community Health Systems Rocked on Lower Guidance, Hospital Woes Continue

Envision Falls Short on Earnings and Guidance

Viventia Files for IPO

Eli Lilly Rises on Bottom Line Beat

The Strongest Performing Biotech in 2015 Is a Surprise

Marijuana Use Doubles in 10 Years

Neogenomics Gears Up to Acquire GE’s Clarient

What to Expect From Eli Lilly Earnings

Biogen Beats on Both Top and Bottom Lines

Corbus Wins With FDA Fast Track Designation

Merus Files for IPO

Q3 Worst for Biotech in 7 Years: Which Large Cap Leaders to Buy Now

Myokardia Sets Terms for IPO

Stock Market Live June 10, 2026: S&P 500 (SPY) Sinks on Fear of War

Live Nasdaq Composite: Market Rout Deepens as Inflation Hits Three-Year High and Oil Climbs

SCHD vs. VYM: Which Dividend ETF Builds a Better Income Stream?

The Roth Conversion Window Before Social Security: A Retiree’s Tax Strategy Worth $66,000

Trump Has Declared an Iran Deal Imminent 37 Times Already. When Will The Conflict Truly End?

Featured Reads

The Roth Conversion Window Before Social Security: A Retiree's Tax Strategy Worth $66,000

What $6,500 a Month Really Looks Like in Retirement With a $1.7 Million Portfolio